Navigation Links
CuraGen Reports First Quarter 2008 Financial Results
Date:4/22/2008

- CR011-vcMMAE in Phase II for melanoma, to begin Phase II for breast

cancer -

- Conference call to be hosted today at 9:00 a.m. EDT -

BRANFORD, Conn., April 22 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) today reported its financial results for the first quarter of 2008. For the quarter ended March 31, 2008, CuraGen reported a net loss of $6.8 million, or $0.12 per share, compared to a net loss of $17.0 million, or $0.31 per share, for the same period in 2007.

During the first quarter, CuraGen incurred costs totaling $1.5 million for milestones related to the advancement of CR011-vcMMAE into Phase II clinical development. Of the decrease in cash and investments of $7.6 million during the first quarter of 2008, $2.6 million was related to non-recurring restructuring payments and payments associated with a previously discontinued program.

As of March 31, 2008, CuraGen had cash, restricted cash and investments of approximately $107.4 million. Following this morning's announced transaction with TopoTarget A/S, CuraGen currently projects a total of approximately $145 million in cash, restricted cash and investments at April 30, 2008.

CuraGen has also revised its 2008 financial guidance. CuraGen anticipates ending 2008 with approximately $135 million of cash and investments compared to previously provided guidance of $90 million. During the second half of 2008, CuraGen anticipates using approximately $6 to $8 million of cash and investments to fund operations.

"During the first quarter we continued to make progress strengthening our balance sheet and working to enhance shareholder value. We believe that our increased cash position and reduced ant
'/>"/>

SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA
2. CuraGen Reports Third Quarter 2007 Financial Results
3. CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference
4. Albemarle Reports Record Quarterly Net Sales and Operating Results
5. Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
6. Amylin Pharmaceuticals Reports First Quarter Financial Results
7. QMed, Inc. Reports First Quarter Results
8. TeamStaff, Inc. Reports Preliminary Second Quarter 2008 Results
9. Bioniche Reports the Passing of its Board Chair
10. Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36
11. Torchmark Corporation Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... WEDNESDAY, Aug. 20, 2014 (HealthDay News) -- Pigs, hearts ... which is twice as long as previously achieved, researchers ... find ways to use animal organs to shorten transplant ... from genetically engineered piglets into baboons, abdomens. The genetic ... system response are what enabled the hearts to survive ...
(Date:8/20/2014)... WEDNESDAY, Aug. 20, 2014 (HealthDay News) -- Loss of ... help explain why many seniors have trouble falling and ... patients, sleep disruption can be especially severe and often ... researchers. The investigators analyzed data from the Rush ... who enrolled at age 65 and are being followed ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. ... cells grow may help doctors diagnose and treat the most ... have found that the deadliest skin cancers occur most often ... long history of sun exposure. These lesions also grow ... cell growth -- called "high mitotic rate" -- is ...
(Date:8/20/2014)... The Board of Directors of top ... is pleased to announce the expansion of its ... and the surrounding region. In support of this ... AIA has relocated to the firm’s office in Shanghai, ... and design and to better support regional clients. ...
(Date:8/20/2014)... Tuberculosis is one of the most persistent and deadliest ... million people each year. , Scientists who study tuberculosis ... tuberculosis likely spread from humans in Africa to seals ... America and transmitted it to Native people there before ... Mycobacterial Genomes Reveal Seals as a Source of New ...
Breaking Medicine News(10 mins):Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:New research shows seals and sea lions likely spread tuberculosis to humans 2Health News:New research shows seals and sea lions likely spread tuberculosis to humans 3
... scientists have found that a deficiency in a key tumor suppressor ... adult brain cancer. The study, conducted in mice that mimic human ... way to screen for the disease early. Appearing June 2 ... show for the first time that:, Glioblastoma, the type of ...
... Clinic researchers have demonstrated that a noninvasive screening test can ... above the colon -- including pancreas, stomach, biliary and esophageal ... studies being presented at Digestive Disease Week 2009 in Chicago, ... account for approximately one in four cancer deaths. While high ...
... at regulatory and clinical concerns with generic immunosuppression medications ... advisory by the International Society for Heart and Lung ... Journal of Heart and Lung Transplantation ( ... Thoracic transplant patients require immunosuppressant medications ...
... from prolonged flexing of the elbow, experts say , ... Then, Guitar Hero wrist. Now, for the latest affliction of ... as cubital tunnel syndrome, cell phone elbow is numbness, tingling ... of the ulnar nerve, which passes along the bony bump ...
... , First hospital in Georgia to use a ... improve patient care and outcomes. , , WOBURN, ... Memorial University Medical Center in Savannah, Georgia has ... to 3 days earlier than conventional methods to help their ...
... initiate phase II trial in hepatic encephalopathy - , ... Inc. today announced top-line results from a phase I study ... presented as part of the 2009 Digestive Disease Week meeting. ... a Novel Ammonia-Reducing Agent in Healthy Adults and Patients with ...
Cached Medicine News:Health News:Most common brain cancer may start in neural stem cells 2Health News:Most common brain cancer may start in neural stem cells 3Health News:Most common brain cancer may start in neural stem cells 4Health News:Improved DNA stool test could detect digestive cancers in multiple organs 2Health News:Improved DNA stool test could detect digestive cancers in multiple organs 3Health News:More stringent evaluation on the use of generic medications in thoracic transplantation 2Health News:'Cell Phone Elbow' -- A New Ill for the Wired Age 2Health News:'Cell Phone Elbow' -- A New Ill for the Wired Age 3Health News:Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 2Health News:Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 3Health News:Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 2Health News:Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 3Health News:Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis 4
(Date:8/20/2014)... Aug. 20, 2014 Torrance Memorial Medical ... advanced, ventilator technology from Covidien to provide a ... patients. The acute care ventilator is ... to conventional mechanical ventilation, and help clinicians move ... Patients on mechanical ventilation are often sedated to ...
(Date:8/20/2014)... Aug. 20, 2014 The National Necrotizing Fasciitis Foundation ... has been successfully treated for a life threatening form ... Anibal R. Gauto , Medical Director of Inpatient Wound Care ... Center in Rancho Mirage, California . ... Dr. John Crew at Seton Hospital in ...
(Date:8/20/2014)... 20, 2014 Research and Markets ... "Global Advanced Wound Care and Closure Market (Types, ... Global Trends, Company Profiles, Demand, Insights, Analysis, Research, ... report to their offering. ... and closure market (types, applications, end user and ...
Breaking Medicine Technology:Torrance Memorial Medical Center Acquires Advanced Ventilator Technology to Enhance Patient Care 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2
... A new study lead by James M. ... School of,Medicine and presented by Charles Simone II, ... that when it comes to seeking,information on the ... from English-speaking patients with regards to,both frequency of ...
... 31 A recent outbreak of MRSA,(Methicillin- resistant ... should cause organizations and facilities nationwide to,reevaluate and ... is resistant to common antibiotics. It manifests its,symptoms ... other pus-filled,lesions. Superbug infections prior to 2007 were ...
Cached Medicine Technology:University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites 2University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites 3'Superbug' Outbreak Calls for Immediate Increased Attention on Infection Control 2
For the rapid determination of human chorionic gonadotropin (hCG) in urine and serum. The test strip is used to obtain a visual qualitative result....
... GE Healthcares new Vivid ... miniaturized cardiovascular ultrasound system to provide high-performance, ... , Vivid i addresses ... care access to complete, real-time diagnostic ...
... The Bio-Quant, Inc. CRP test is ... vitro test. It is designed for ... (CRP) in human serum or whole ... concentration in serum or whole blood ...
The Bio-Quant CK-MB test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of,CK-MB in human serum specimens as an aid in the diagnosis of myocar...
Medicine Products: